Variable | L-PCLND | O-PCLND | p Value |
---|---|---|---|
N = 46 | N = 21 | ||
Clinical stage Lugano; n (%) | |||
CS IIa | 6 (13.0) | 1 (4.8) | 0.586 *1 |
CS IIb | 14 (30.4) | 5 (23.8) | |
CS IIc | 6 (13.0) | 3 (14.3) | |
CS IIIa | 7 (15.2) | 2 (9.5) | |
CS IIIb | 5 (10.9) | 2 (9.5) | |
CS IIIc | 8 (17.4) | 8 (38.1) | |
Resected template; n (%) | |||
radical bilateral | 12 (26.0) | 13 (61.9) | 0.002 *1 |
modified template resection*3 | 32 (69.5) | 5 (23.8) | |
lumpectomy | 2 (4.3) | 0 (0) | |
Median age; yrs (IQR) | 32.0 (26.5 – 37.5) | 28.0 (22.0 – 34.0) | 0.521 *2 |
Median BMI; kg/m2 (IQR) | 24.0 (21.8 – 26.2) | 22.6 (19.3 – 25.8) | 0.789 *2 |
Median operative time; min (IQR) | 212.0 (145 – 298) | 232.5 (181 – 424) | 0.256 *2 |
Insertion of wound drainage tube; n (%) | 12 (26.0) | 15 (71.4) | <0.001 *1 |
Median duration of drainage tube; days (IQR) | 0.0 (0.0 – 1.0) | 3.5 (2.0 – 6.5) | <0.001 *2 |
Median duration of hospital stay; days (IQR) | 6.0 (5.0 – 7.5) | 11.5 (7.0 – 16.5) | 0.002 *2 |
Intraoperative complications; n (%) | |||
none | 36 (78.3) | 13 (61.9) | 0.244 *1 |
Clavien I | 0 (0) | 1 (4.7) | |
Clavien II | 1 (2.2) | 1 (4.7) | |
Clavien III | 9 (19.6) | 6 (28.5) | |
Intraoperative conversion rate; n (%) | 3 (6.5) | 0 (0) | n.a. |
Blood loss categories; n (%) | |||
n.s. < 100 ml | 41 (89.1) | 15 (71.4) | 0.076 *1 |
100-500 ml without transfusion | 1 (2.1) | 3 (14.2) | |
>500 ml or transfusion | 4 (8.6) | 3 (14.2) | |
Intraoperative kidney resection; n (%) | 0 (0) | 3 (14.3) | 0.028 *1 |
Major vascular injuries; n (%) | 12 (26.0) | 4 (19.0) | 0.758 *1 |
Postoperative complications; n (%)*4 | 0.431 *1 | ||
none | 41 (89.1) | 18 (85.7) | |
Clavien I | 4 (8.7) | 2 (9.5) | |
Clavien III | 0 (0) | 1 (4.8) |